Phase 3, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC...

Date 28 September 2015
Event European Cancer Congress 2015
Session Lung Cancer - Metastatic Disease
Topics Non-Small-Cell Lung Cancer, Metastatic
Presenter Horn, L.